The Role of Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

To assess the sensitivity and accuracy of diffusion magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) metrics, in identifying early-stage changes in brain white matter related to various white matter diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Adults aged 18-80 years.

• Clinical suspicion of early-stage white matter disease.

• No prior diagnosis of significant neurological disorders (e.g., stroke, brain tumors).

• Ability to provide informed consent.

Locations
Other Locations
Egypt
General Authority for Teaching Hospitals and Institutes
RECRUITING
Cairo
Contact Information
Primary
Hekmat S Baumey, MD
hekmattsamir@gmail.com
00201555433546
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 150
Treatments
Study group
Patients diagnosed with suspected early-stage white matter disease (e.g., multiple sclerosis, small vessel disease, Alzheimer's disease, frontotemporal dementia, leukoaraiosis) will be enrolled.
Related Therapeutic Areas
Sponsors
Leads: The General Authority for Teaching Hospitals and Institutes

This content was sourced from clinicaltrials.gov